Editorial Commentary: The Dawning of Microbiome Remediation for Addressing Antibiotic Resistance.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Gut Microbiome-Based Strategies for the Control of Carbapenem-Resistant Enterobacteriaceae.Journal of microbiology and biotechnology · 2025
   Review
2. High prevalence of multi-drug resistant organisms in the gut flora of healthy rural individuals in northern India.The Indian journal of medical research · 2024
   Article
3. Respiratory Microbiome Disruption and Risk for Ventilator-Associated Lower Respiratory Tract Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
   Article
4. The Role of Fecal Microbiota Transplantation in Reducing Intestinal Colonization With Antibiotic-Resistant Organisms: The Current Landscape and Future Directions.Open forum infectious diseases · 2019
   Article
5. Microbiome as a tool and a target in the effort to address antimicrobial resistance.Proceedings of the National Academy of Sciences of the United States of America · 2018
   Article
6. Durability and Long-term Clinical Outcomes of Fecal Microbiota Transplant Treatment in Patients With Recurrent Clostridium difficile Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
   Article
7. Fecal Microbiota Transplant for RefractoryOpen forum infectious diseases · 2018
   Article
8. Microbial Disruption Indices to Detect Colonization With Multidrug-Resistant Organisms.Infection control and hospital epidemiology · 2017
   Article
9. Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient?Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
   Review
10. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.Gut microbes · 2017
    Review
11. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.Genome medicine · 2017
    Article
12. Predominance of Lactobacillus spp. Among Patients Who Do Not Acquire Multidrug-Resistant Organisms.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article

Corrections and comments

• Comment on
  Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection.2016

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as